Takeda

Global CSR Program 2025: Vitamin Angels | Takeda Pharmaceuticals

Community health workers providing nutritional support to mothers and young children as part of a maternal and child health program in Indonesia.

Transforming nutrition supply chains and supplementation in climate-affected communities in Indonesia

Preventing child deaths and improving health outcomes for 12.1 million people by scaling integrated nutrition interventions nationwide

Vitamin Angels logo

The Program


Partner: Vitamin Angels

Budget: 1,212 million yen

Term: 5 years

Launch: 2025

Area: Indonesia

Visit the Vitamin Angels websiteGo to https://vitaminangels.org/

Indonesia faces severe nutrition challenges exacerbated by climate-related events such as floods, droughts, and pestilence. These events hinder the growth and distribution of nutritious food, leading to devastating short-term consequences like stillbirth, stunting, and wasting, as well as lifelong impacts such as impaired mental development and increased risk of disease and disability. Pregnant women, mothers, and children are particularly vulnerable. In 2024, climate change-induced malnutrition led to a 10% decrease in years of healthy life, while excess heat exposure increased the risk of stillbirth by 18% and pre-term birth by 16%1.

Partnering with the Indonesian government, the program strengthens national nutrition policies and funding to address climate change. It localizes production and distribution of nutrition products, reducing environmental impact. The initiative expands access to proven interventions—prenatal multivitamins, vitamin A supplementation, deworming, breastfeeding support, and nutrition education—to protect mothers and children from climate-driven health risks. Additionally, about one million health workers will be trained to identify and treat climate-related nutritional deficiencies, strengthening Indonesia’s health system for the future.

Takeda’s support is pivotal in building a climate-resilient nutrition supply chain and health system in Indonesia. Over five years, the program will benefit 12.1 million people—providing prenatal multivitamins to approximately 8.6 million women and babies annually and vitamin A and deworming treatments to 3.6 million under-five children. The program aims to strengthen policies, supply chain and health work capacity. Takeda’s support reinforces the objective to drive rapid and sustainable improvements in the health of Indonesia’s most vulnerable communities.

A mother holding a young child while receiving nutrition-related support at a community health setting.
Healthcare workers participating in a training session on nutrition and maternal and child health.

Photo credit: Vitamin Angels

Have more questions?


Contact us if you'd like more information about our Global CSR Program.